Alvotech wins UK High Court case against Regeneron and Bayer for biosimilar manufacturing.

lunes, 10 de noviembre de 2025, 4:02 am ET1 min de lectura
ALVO--

Alvotech, a global biotech company, has won expedited infringement proceedings against Regeneron and Bayer in the UK High Court. The court rejected the request for an injunction on manufacturing activities for Alvotech's biosimilar to Eylea, supporting commercial launches in the European Economic Area and other countries after the expiry date for Supplementary Protection Certificates on November 23, 2025.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios